PubMed

Octreotide-induced manic episodes in a patient with acromegaly.

Fernández-Real JM, Recasens M, Ricart W.

Ann Intern Med. 2006 May 2;144(9):704. No abstract available. PMID: 16670150 [PubMed - indexed for MEDLINE]Related articlesFree article

Hair loss in three patients with acromegaly treated with octreotide.

Lami MC, Hadjadj S, Guillet G.

Br J Dermatol. 2003 Sep;149(3):655-6. No abstract available. PMID: 14511007 [PubMed - indexed for MEDLINE]Related articles

Heart failure and octreotide in acromegaly.

Chanson P, Timsit J, Harris AG.

Lancet. 1992 Jan 25;339(8787):242-3. No abstract available. PMID: 1346193 [PubMed - indexed for MEDLINE]Related articles

Gall stones and treatment with octreotide for acromegaly.

[No authors listed]

BMJ. 1989 Nov 4;299(6708):1162-3. No abstract available. PMID: 2513036 [PubMed - indexed for MEDLINE]Related articlesFree article

Octreotide dependency and headache: a case report.

May A, Lederbogen S, Diener HC.

Cephalalgia. 1994 Aug;14(4):303-4.PMID: 7954762 [PubMed - indexed for MEDLINE]Related articles

Acute hepatitis after treatment of acromegaly with octreotide.

Arosio M, Bazzoni N, Ambrosi B, Faglia G.

Lancet. 1988 Dec 24-31;2(8626-8627):1498. No abstract available. PMID: 2904619 [PubMed - indexed for MEDLINE]Related articles

Congestive heart failure worsening with octreotide in acromegalic patient.

Leclerq F, Fille A, Albat B, Bringer J, Grolleau R, Jaffiol C.

Lancet. 1991 Nov 16;338(8777):1272-3. No abstract available. PMID: 1682667 [PubMed - indexed for MEDLINE]Related articles

Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.

Hofmann AF.

Gut. 2005 May;54(5):575-8. No abstract available. PMID: 15831896 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute pancreatitis following octreotide withdrawal.

Sadoul JL, Benchimol D, Thyss A, Freychet P.

Am J Med. 1991 Jun;90(6):763-4. No abstract available. PMID: 2042694 [PubMed - indexed for MEDLINE]Related articles

Deterioration of glycemic control during octreotide LAR treatment in an acromegalic Japanese patient with type 2 diabetes mellitus.

Kahara T, Ueno K, Torita M, Usuda R, Abe T.

Endocr J. 2007 Apr;54(2):329-33. Epub 2007 Mar 6.PMID: 17339747 [PubMed - indexed for MEDLINE]Related articlesFree article

Slow intestinal transit and gallstone formation.

Hussaini SH, Pereira SP, Dowling RH, Wass JA.

Lancet. 1993 Mar 6;341(8845):638. No abstract available. PMID: 8094871 [PubMed - indexed for MEDLINE]Related articles

A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly.

Murray RD, Melmed S.

J Clin Endocrinol Metab. 2008 Aug;93(8):2957-68. Epub 2008 May 13. Review.PMID: 18477663 [PubMed - indexed for MEDLINE]Related articlesFree article

[Usefulness of GH and IGF-1 to establish the dose and frequency of application of octreotide to treat acromegaly]

Martínez-Delgado IA, Gómez-Martínez G.

Rev Med Inst Mex Seguro Soc. 2007 May-Jun;45(3):291-5. Spanish. PMID: 17692168 [PubMed - indexed for MEDLINE]Related articles

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.

Mercado M, Borges F, Bouterfa H, Chang TC, Chervin A, Farrall AJ, Patocs A, Petersenn S, Podoba J, Safari M, Wardlaw J; SMS995B2401 Study Group.

Clin Endocrinol (Oxf). 2007 Jun;66(6):859-68. Epub 2007 Apr 25.PMID: 17465997 [PubMed - indexed for MEDLINE]Related articlesFree article

No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly.

Colao A, Marek J, Goth MI, Caron P, Kuhn JM, Minuto FM, Weissman NJ.

J Clin Endocrinol Metab. 2008 Jun;93(6):2243-8. Epub 2008 Apr 1.PMID: 18381583 [PubMed - indexed for MEDLINE]Related articlesFree article

Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly.

Jawiarczyk A, Kałuzny M, Bolanowski M, Bednarek-Tupikowska G.

Neuro Endocrinol Lett. 2008 Aug;29(4):571-6.PMID: 18766168 [PubMed - indexed for MEDLINE]Related articles

Gall stones induced by octreotide.

Catnach SM, Wass JA, Anderson JV, Besser M, Fairclough P, Hussaini H, Dowling H.

BMJ. 1992 Aug 1;305(6848):313. No abstract available. PMID: 1392873 [PubMed - indexed for MEDLINE]Related articlesFree article

Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide.

Yetkin DO, Boysan SN, Tiryakioglu O, Yalin AS, Kadioglu P.

Endocr J. 2007 Jun;54(3):459-64. Epub 2007 May 9.PMID: 17495423 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant.

Feenstra J, van Aken MO, de Herder WW, Feelders RA, van der Lely AJ.

Eur J Endocrinol. 2006 Jun;154(6):805-6.PMID: 16728538 [PubMed - indexed for MEDLINE]Related articlesFree article

Pituitary tumor enlargement in two patients with acromegaly during pegvisomant therapy.

Frohman LA, Bonert V.

Pituitary. 2007;10(3):283-9.PMID: 17534717 [PubMed - indexed for MEDLINE]Related articles